Cargando…
Non-targeted proteomics of acute respiratory distress syndrome: clinical and research applications
Acute respiratory distress syndrome (ARDS) is characterized by refractory hypoxemia caused by accumulation of pulmonary fluid with a high mortality rate, but the underlying mechanism is not yet fully understood, causing absent specific therapeutic drugs to treat with ARDS. In recent years, more and...
Autores principales: | Wen, Xu-Peng, Zhang, Yue-Zhong, Wan, Qi-Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980750/ https://www.ncbi.nlm.nih.gov/pubmed/33743690 http://dx.doi.org/10.1186/s12953-021-00174-y |
Ejemplares similares
-
Application of clinical proteomics in acute respiratory distress syndrome
por: Bhargava, Maneesh, et al.
Publicado: (2014) -
Proteomic Profiles in Acute Respiratory Distress Syndrome Differentiates Survivors from Non-Survivors
por: Bhargava, Maneesh, et al.
Publicado: (2014) -
Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design
por: Qiao, Qi, et al.
Publicado: (2021) -
Identification of potential biomarkers and therapeutic targets for posttraumatic acute respiratory distress syndrome
por: Qi, Peng, et al.
Publicado: (2023) -
Oxygenation target in acute respiratory distress syndrome
por: Capellier, Gilles, et al.
Publicado: (2023)